🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Singapore / NCT07141160
Enrolling by invitation Not applicable

ADL+2.0: Intervention for Prevention of Cognitive Decline in Community-dwelling Older Adults

NCT07141160 · tracked via the Priya Life Science Singapore tracker
Phase
Not applicable
Started
2025-05-08
Last updated
2025-12-17

Condition(s) studied

Cognitive Decline

Investigational drug(s) / intervention(s)

Combined: Mobile app + 6WELLSRemote mobile based app

Combined: Mobile app + 6WELLS: Mobile based digital toolkit for cognitive health, remote assessment and multi-component intervention, comprising the 4 key pillars of assessment; cognitive training and stimulation; cognitive wellness; and dual-task training. Together with onsite 6 WELLS Group-Based Activity is a structured, group-based, cognitive health promotion programme that aims to build communities of practice, stimulate goal attainment, and drive behavioural change towards cognitive health and wellbeing. The curriculum is delivered via a 10-week onsite programme comprising weekly facilitated small-group activities centred on six key components.

Remote mobile based app: Mobile based digital toolkit for cognitive health, remote assessment and multi-component intervention, comprising the 4 key pillars of assessment; cognitive training and stimulation; cognitive wellness; and dual-task training.

Study summary

Singapore's rising dementia incidence with an ageing population presents an urgent need for effective interventions that delay or prevent cognitive decline. While multi-domain intervention studies for dementia prevention show promise, there is a need for an effective personalised approach to address an individual's multifactorial risks for dementia, and to achieve cost-effective, scalable and sustainable outcomes for wider implementation.

The investigators propose the ADL+ 2.0 programme, an overall goal is to delay or prevent cognitive decline in at-risk individuals without dementia aged 60 and above with subjective memory complaints and/or impaired cognitive capacity from the ICOPE screening tool. Through a population-level, technology-enabled, community-based preventative approach, ADL+ 2.0 provides remote assessment and multi-component intervention (cognitive training, dual-task exercises, and cognitive wellness) with smart scheduling and personalized intervention, and can be delivered in conjunction with the onsite 6 WELLS facilitated group-based activity, underpinned by the Self-Determination Theory to foster intrinsic motivation for lasting behavioural change.

The approach begins with phase 1 test-bedding approach Type 1 hybrid effectiveness-implementation study to ascertain the efficacy, cost-effectiveness, and implementation of the ADL+ 2.0 programme. The investigators will conduct a 3-arm cluster-randomised controlled trial comparing remote/onsite, remote only, and control groups to assess the impact on cognitive outcomes, social networks, quality-of-life and cost-effectiveness. Barriers and facilitators will be identified for implementation, guided by the Consolidated Framework for Implementation Research.

Together with NTU-LILY/LKCMedicine as technology partner and community partners (NTUC Health, Fei Yue Community Services, and evaluation partners (GERI/NUS) to provide evidence for and effectively implement a scalable, sustainable, and cost-effective community programme for the prevention of cognitive decline in Singapore.

Eligibility

Sex
ALL
Min age
60 Years
Max age
99 Years
Healthy volunteers
Accepted
Inclusion Criteria: * ≥60 Years old * Participants from partnering Active Ageing Centres (AACs) across Singapore * Subjective memory complaint (AD8 ≥ 2) * Independent in activities of daily living (ADL) * Able to speak English and/or Mandarin * Comfortable with using smartphones * Not currently enrolled in a formal cognitive training program. Exclusion Criteria: * Known dementia or suspected dementia after initial screening * Significant medical illnesses

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tan Tock Seng Hospital Singapore Singapore

More Tan Tock Seng Hospital trials in Singapore

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07141160 on ClinicalTrials.gov ↗ ← All trials in Singapore